Comparison of colonic transit time between patients with constipation-predominant irritable bowel syndrome and functional constipation

被引:11
|
作者
Ansari R. [1 ]
Sohrabi S. [1 ]
Ghanaie O. [1 ]
Amjadi H. [1 ]
Merat S. [1 ]
Vahedi H. [1 ]
Khatibian M. [1 ]
机构
[1] Digestive, Disease Research Center, Shariati Hospital, Tehran University of Medical Sciences, 14117 Tehran, North Kargar Avenue
关键词
Bowel motility; Functional bowel disease;
D O I
10.1007/s12664-010-0015-2
中图分类号
学科分类号
摘要
Background/Aim Functional constipation (FC) and consti-pation-predominant IBS (C-IBS) are two main subtypes of constipation. Using radio-opaque markers is an easy and cost effective method to measure colonic transit time (CTT). We designed this study to compare the CTT between these two groups of constipated patients. Methods Patients with chronic constipation of no organic etiology were classified as having FC or C-IBS according to the Rome II criteria. All patients ingested 10 radio opaque markers daily for six days. A plain abdominal X-ray was taken on the seventh day. To calculate the total and segmental colonic transit time in hours, number of markers in right and left colonic and rectosigmoid area were counted and multiplied by 2.4. The mean total and segmental colonic transit time were compared between the two groups. Results A total of 100 patients (50 FC and 50 C-IBS) were enrolled. The mean (SD) total CTT was not significantly different between FC patients (52.2 [35.5] h) and C-IBS patients (41.2 [31.6] h; p = 0.10). The mean rectosigmoid transit time was significantly slower in FC patients (19.9 [15.5] h) com-pared to C-IBS patients (11.9 [10.6] h; p = 0.003). Conclusion Rectosigmoid transit time in FC patients is slower than in C-IBS patients.
引用
收藏
页码:66 / 68
页数:2
相关论文
共 50 条
  • [21] Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements
    Jingyuan Luo
    Qianqian Xu
    Shujun Xu
    Lixiang Zhai
    Chun-Su Yuan
    Zhaoxiang Bian
    Current Gastroenterology Reports, 2025, 27 (1)
  • [22] Plecanatide for the treatment of constipation-predominant irritable bowel syndrome
    Miner, Philip B.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (02) : 71 - 84
  • [23] CONSTIPATION-PREDOMINANT IRRITABLE BOWEL SYNDROME AND FUNCTIONAL CONSTIPATION ARE NOT DISCRETE DISORDERS: A MACHINE LEARNING APPROACH
    Ruffle, James
    Tinkler, Linda
    Emmett, Christopher
    Ford, Alex
    Nachev, Parashkev
    Aziz, Qasim
    Farmer, Adam
    Yiannakou, Yan
    GUT, 2021, 70 : A218 - A218
  • [24] Antibiotic Treatment of Constipation-Predominant Irritable Bowel Syndrome
    Pimentel, Mark
    Chang, Christopher
    Chua, Kathleen Shari
    Mirocha, James
    DiBaise, John
    Rao, Satish
    Amichai, Meridythe
    DIGESTIVE DISEASES AND SCIENCES, 2014, 59 (06) : 1278 - 1285
  • [25] White Matter Microstructural Similarity and Diversity of Functional Constipation and Constipation-predominant Irritable Bowel Syndrome
    Nan, Jiaofen
    Zhang, Liangliang
    Chen, Qiqiang
    Zong, Nannan
    Zhang, Peiyong
    Ji, Xing
    Ma, Shaohui
    Zhang, Yuchen
    Huang, Wei
    Du, Zhongzhou
    Xia, Yongquan
    Zhang, Ming
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (01) : 107 - 118
  • [26] Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation
    Eswaran, Shanti
    Guentner, Amanda
    Chey, William D.
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 20 (02) : 141 - 151
  • [27] Renzapride accelerates colonic transit and improves bowel function in constipation-predominant irritable bowel syndrome (C-IBS)
    Camilleri, M
    McKinzie, S
    Fox, J
    Foxx-Orenstein, A
    Burton, D
    Thomforde, G
    Baxter, K
    Zinsmeister, A
    GASTROENTEROLOGY, 2004, 126 (04) : A642 - A642
  • [28] Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC)
    Zhao, Y. -F.
    Ma, X. -Q.
    Wang, R.
    Yan, X. -Y.
    Li, Z. -S.
    Zou, D. -W.
    He, J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1020 - 1029
  • [29] Dose-Related Effects of Chenodeoxycholate on Gastrointestinal and Colonic Transit and Bowel Function in Female Patients With Constipation-Predominant Irritable Bowel Syndrome
    Rao, Archana S.
    Odunsi, Suwebatu T.
    Camilleri, Michael
    McKinzie, Sanna
    Burton, Duane D.
    Singh, Ravinder J.
    Lamsam, Jesse
    Zinsmeister, Alan R.
    GASTROENTEROLOGY, 2010, 138 (05) : S224 - S224
  • [30] Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
    Enck, Paul
    Leinert, Johannes
    Smid, Menno
    Koehler, Thorsten
    Schwille-Kiuntke, Juliane
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2016, 2016